恒瑞医药: 恒瑞医药关于召开2024年年度股东会的通知

Group 1 - The annual general meeting of Jiangsu Hengrui Medicine Co., Ltd. is scheduled for April 28, 2025, at 14:30 [1][3] - The meeting will utilize the Shanghai Stock Exchange's online voting system, with voting available from 9:15 to 15:00 on the same day [1][3] - Shareholders can vote through both on-site and online methods, ensuring broader participation [3][5] Group 2 - The agenda includes proposals for the company's dividend return plan for the next three years (2025-2027), the reappointment of the auditing firm for 2025, and the review of executive compensation for 2024 [2][4] - The proposals have been approved in previous board meetings held on March 28, April 2, and announced on March 31 and April 3 [2][4] - Shareholders with conflicts of interest are required to abstain from voting on relevant proposals [2] Group 3 - Shareholders must register to attend the meeting, providing necessary documentation such as stock account cards and identification [6][7] - Registration will take place on April 18, 2025, from 9:30 to 16:00 at the company's securities affairs department [7] - The company will offer a reminder service to shareholders via SMS to encourage participation [5][6]